Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative medications work by mimicking the inherent actions of GLP-1, a hormone produced by the https://todaybookmarks.com/story20919234/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes